Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047

Guide to receptors and channels (GRAC), 5th edition

Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947

The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats

Grill, H. J., & Norgren, R. (1978) · Brain Research · doi:10.1016/0006-8993(78)90568-1 · Cited by 1,220

G Protein-Coupled Receptor Allosterism and Complexing

Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 934

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878

Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850

Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro

Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763

Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat

Cechetto, D. F., & Saper, C. B. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902620104 · Cited by 703

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669

The pharmacokinetics and the pharmacodynamics of cannabinoids

Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724

Cannabidiol as a Potential Treatment for Anxiety Disorders

Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752

Molecular Targets of the Phytocannabinoids: A Complex Picture

Morales, P., Hurst, D. P., & Reggio, P. H. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_4 · Cited by 499

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475

Cannabidiol, neuroprotection and neuropsychiatric disorders

Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

Gregorio, D. D., McLaughlin, R. J., Posa, L., Ochoa‐Sanchez, R., Enns, J. P., López-Canul, M., Aboud, M. K., Maione, S., Comai, S., & Gobbi, G. (2018) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 413

Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Fernández‐Ruíz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R. G., Mechoulam, R., & Martínez-Orgado, J. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 364

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

Mlost, J., Bryk, M., & Starowicz, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228870 · Cited by 315

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 315

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors

Linge, R., Jiménez-Sánchez, L., Campa, L., Pilar-Cuéllar, F., Vidal, R., Pazos, Á., Adell, A., & Díaz, Á. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.017 · Cited by 293

Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users

Bonn-Miller, M. O., Boden, M. T., Bucossi, M. M., & Babson, K. A. (2014) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.821477 · Cited by 281

Molecular Pharmacology of Phytocannabinoids

Turner, S. E., Williams, C. M., Iversen, L. L., & Whalley, B. J. (2017) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-319-45541-9_3 · Cited by 264

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

Hill, M. N., Campolongo, P., Yehuda, R., & Patel, S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.162 · Cited by 250

The endocannabinoid system as a target for novel anxiolytic drugs

Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233

Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors

Pazos, M. R., Mohammed, N., Lafuente, H., Santos, M., Martínez‐Pinilla, E., Moreno, E., Valdizán, E. M., Romero, J., Pazos, Á., Franco, R., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.027 · Cited by 223

The Pharmacological Case for Cannabigerol

Nachnani, R., Raup‐Konsavage, W. M., & Vrana, K. E. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000340 · Cited by 227

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.001 · Cited by 216

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors

Martínez‐Pinilla, E., Varani, K., Reyes‐Resina, I., Angelats, E., Vincenzi, F., Ferreiro‐Vera, C., Oyarzábal, J., Canela, E. I., Lanciego, J. L., Nadal, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00744 · Cited by 200

Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system

Sharkey, K. A., Darmani, N. A., & Parker, L. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.068 · Cited by 204

An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol

Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 188

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175

Beyond THC and Endocannabinoids

Pacher, P., Kogan, N. M., & Mechoulam, R. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021441 · Cited by 175

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death

Rimmerman, N., Ben-Hail, D., Porat, Z., Juknat, A., Kozela, E., Daniels, M. P., Connelly, P. S., Leishman, E., Bradshaw, H. B., Shoshan‐Barmatz, V., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.471 · Cited by 164

The Polypharmacological Effects of Cannabidiol

Castillo-Arellano, J. I., Canseco-Alba, A., Cutler, S. J., & León, F. (2023) · Molecules · doi:10.3390/molecules28073271 · Cited by 172

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Peres, F. F., Lima, A. C., Hallak, J. E. C., Crippa, J. A. S., Silva, R. H., & Abílio, V. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00482 · Cited by 167

Constituents of Cannabis Sativa

Rock, E. M., & Parker, L. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_1 · Cited by 171

Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors

Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.01.033 · Cited by 156

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151

Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer

Kis, B., Ifrim, F. C., Buda, V. O., Avram, Ș., Pavel, I. Z., Antal, D., Păunescu, V., Dehelean, C. A., Ardelean, F., Diaconeasa, Z. M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235905 · Cited by 148

Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation

Kopustinskienė, D. M., Masteiková, R., Lažauskas, R., & Bernatonienė, J. (2022) · Antioxidants · doi:10.3390/antiox11040660 · Cited by 155

Conditioned flavor avoidance and conditioned gaping: Rat models of conditioned nausea

Parker, L. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.070 · Cited by 147

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139

Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

Patricio, F., Morales-Andrade, A. A., Patricio-Martínez, A., & Limón, I. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595635 · Cited by 129

The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease

Hasenoehrl, C., Taschler, U., Storr, M., & Schicho, R. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12931 · Cited by 121

Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels

Sales, A. J., Crestani, C. C., Guimarães, F. S., & Joca, S. R. L. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.002 · Cited by 118

Endocannabinoids: A unique opportunity to develop multitarget analgesics

Maione, S., Costa, B., & Marzo, V. D. (2013) · Pain · doi:10.1016/j.pain.2013.03.023 · Cited by 104

Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

Turna, J., Patterson, B. A., & Ameringen, M. V. (2017) · Depression and Anxiety · doi:10.1002/da.22664 · Cited by 107

Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1activation

Stanley, C. P., Hind, W. H., Tufarelli, C., & O’Sullivan, S. E. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv179 · Cited by 100

Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials

de Bitencourt, R. M., & Takahashi, R. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00502 · Cited by 108

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence

Rohleder, C., Müller, J. K., Lange, B., & Leweke, F. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00422 · Cited by 94

Therapeutic Potential of Cannabinoids in Psychosis

Leweke, F. M., Mueller, J. K., Lange, B., & Rohleder, C. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.018 · Cited by 96

Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease

Silvestro, S., Schepici, G., Bramanti, P., & Mazzon, E. (2020) · Molecules · doi:10.3390/molecules25215186 · Cited by 93

The Pharmacology and Therapeutic Potential of Plant Cannabinoids

Cascio, M. G., Pertwee, R. G., & Marini, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_9 · Cited by 94

Endocannabinoids, cannabinoids and the regulation of anxiety

Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 91

Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness

Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 82

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 81

The evolving science of phytocannabinoids

Reekie, T. A., Scott, M., & Kassiou, M. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0101 · Cited by 78

Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors

Espejo‐Porras, F., Fernández‐Ruíz, J., Pertwee, R. G., Mechoulam, R., & García, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.024 · Cited by 75

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets

Vitale, R. M., Iannotti, F. A., & Amodeo, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094876 · Cited by 74

Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice

Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.005 · Cited by 77

Pharmacological effects of cannabidiol by transient receptor potential channels

Etemad, L., Karimi, G., Alavi, M. S., & Roohbakhsh, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120582 · Cited by 73

(‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research

Formato, M., Crescente, G., Scognamiglio, M., Fiorentino, A., Pecoraro, M. T., Piccolella, S., Catauro, M., & Pacifico, S. (2020) · Molecules · doi:10.3390/molecules25112638 · Cited by 72

Biosynthesis and synthetic biology of psychoactive natural products

Jamieson, C. S., Misa, J., Tang, Y., & Billingsley, J. M. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00065a · Cited by 74

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review

Hasbi, A., Madras, B. K., & George, S. R. (2023) · Brain Sciences · doi:10.3390/brainsci13020325 · Cited by 69

The phytocannabinoid, Δ9‐tetrahydrocannabivarin, can act through 5‐ HT 1 A receptors to produce antipsychotic effects

Cascio, M. G., Zamberletti, E., Marini, P., Parolaro, D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13000 · Cited by 67

Looking beyond 5-HT3 receptors: A review of the wider role of serotonin in the pharmacology of nausea and vomiting

Johnston, K. D., Lu, Z., & Rudd, J. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.014 · Cited by 67

Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects

Mendiguren, A., Aostri, E., & Pineda, J. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.029 · Cited by 68

Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

Pertwee, R. G., Rock, E. M., Guenther, K. G., Limebeer, C. L., Stevenson, L., Haj, C. G., Smoum, R., Parker, L. A., & Mechoulam, R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14073 · Cited by 66

Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats

Campos, A. C., de Paula Soares, V., Carvalho, M. C., Ferreira, F. R., Vicente, M. A., Brandão, M. L., Zuardi, A. W., Zangrossi, H., & Guimarães, F. S. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2878-7 · Cited by 65

Tetrahydrocannabinolic acid reduces nausea‐induced conditioned gaping in rats and vomiting in S uncus murinus

Rock, E. M., Kopstick, R. L., Limebeer, C. L., & Parker, L. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12316 · Cited by 65

Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t

Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082323 · Cited by 75

The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility

Abalo, R., Vera, G., López-Pérez, A. E., Martínez-Villaluenga, M., & Martı́n, M. I. (2012) · Pharmacology · doi:10.1159/000339072 · Cited by 63

Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study

Devinsky, O., Kraft, K. S., Rusch, L. M., Fein, M., & Leone‐Bay, A. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.012 · Cited by 64

The use of cannabis in supportive care and treatment of brain tumor

Likar, R., & Nahler, G. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npw027 · Cited by 61

Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice

Sonego, A. B., Gomes, F. V., Bel, E. A. D., & Guimarães, F. S. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.04.042 · Cited by 62

A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors

Echeverry, C., Prunell, G., Narbondo, C., de Medina, V. S., Nadal, X., Reyes-Parada, M. I., & Scorza, C. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00277-y · Cited by 64

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

Martínez-Aguirre, C., Carmona-Cruz, F., Velasco, A. L., Velasco, F., Aguado-Carrillo, G., Cuéllar‐Herrera, M., & Rocha, L. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.611278 · Cited by 60

Cannabidiol goes nuclear: The role of PPARγ

Khosropoor, S., Alavi, M. S., Etemad, L., & Roohbakhsh, A. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154771 · Cited by 58

Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis.

Han, K., Wang, J.-Y., Wang, P.-Y., & Peng, Y.-C.-H. (2024) · Psychiatry research · doi:10.1016/j.psychres.2024.116049 · Cited by 54

Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice

Karmaus, P. W. F., Wagner, J. G., Harkema, J. R., Kaminski, N. E., & Kaplan, B. L. F. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.741628 · Cited by 54

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats

Genaro, K., Fabris, D., Arantes, A. L. F., Zuardi, A. W., Crippa, J. A. S., & Prado, W. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00391 · Cited by 55

Natural Salicylates and Their Roles in Human Health

Yeasmin, F., & Choi, H. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239049 · Cited by 56

Effect of low doses of cannabidiolic acid and ondansetron on LiCl ‐induced conditioned gaping (a model of nausea‐induced behaviour) in rats

Rock, E., & Parker, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12162 · Cited by 53

The Impact of Cannabidiol on Psychiatric and Medical Conditions

Oberbarnscheidt, T., & Miller, N. S. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4159 · Cited by 55

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Leweke, F. M., Rohleder, C., Gerth, C. W., Hellmich, M., Pukrop, R., & Koethe, D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614811 · Cited by 53

Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry

Rifkin-Zybutz, R. P., Erridge, S., Holvey, C., Coomber, R., Gaffney, J., Lawn, W., Barros, D. A. R., Bhoskar, U., Mwimba, G., Praveen, K., et al. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06399-3 · Cited by 53

Adverse effects after the use of JWH‐210 – a case series from the EU Spice II plus project

Hermanns‐Clausen, M., Kithinji, J., Spehl, M. S., Angerer, V., Franz, F., Eyer, F., & Auwärter, V. (2016) · Drug Testing and Analysis · doi:10.1002/dta.1936 · Cited by 52

Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System

Schönhofen, P., Bristot, I. J., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., Parsons, R. B., & Klamt, F. (2018) · CNS Drugs · doi:10.1007/s40263-018-0550-4 · Cited by 58

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain

de Ternay, J., Naassïla, M., Nourredine, M., Louvet, A., Bailly, F., Sescousse, G., Maurage, P., Cottencin, O., Carrieri, P., & Rolland, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00627 · Cited by 52

A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping

Rock, E. M., Limebeer, C. L., Navaratnam, R., Sticht, M. A., Bonner, N., Engeland, K., Downey, R. I., Morris, H. I., Jackson, M., & Parker, L. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3498-1 · Cited by 48

Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action

Chaves, Y. C., Genaro, K., Crippa, J. A. S., da Cunha, J. M., & Zanoveli, J. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00667-3 · Cited by 52

Evidences for the Anti-panic Actions of Cannabidiol

Soares-Rachetti, V. D. P., & Campos, A. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160509123955 · Cited by 52

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

Leweke, F. M., Mueller, J. K., Lange, B., Fritze, S., Topor, C. E., Koethe, D., & Rohleder, C. (2018) · CNS Drugs · doi:10.1007/s40263-018-0539-z · Cited by 48

Cannabinoid pharmacology and therapy in gut disorders

Uranga, J. A., Vera, G., & Abalo, R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.048 · Cited by 46

Safety and efficacy of cannabidiol-cannabidiolic acid rich hemp extract in the treatment of refractory epileptic seizures in dogs

Garcia, G. A., Kube, S. A., Carrera‐Justiz, S., Tittle, D., & Wakshlag, J. J. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.939966 · Cited by 50

Cannabinoids As Potential Treatment for Chemotherapy-Induced Nausea and Vomiting

Rock, E. M., & Parker, L. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00221 · Cited by 45

Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs

Bradley, S., Young, S., Bakke, A. M., Holcombe, L. J., Waller, D., Hunt, A. B. G., Pinfold, K., Watson, P., & Logan, D. W. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.977457 · Cited by 44

Cannabinoids: The Lows and the Highs of Chemotherapy-Induced Nausea and Vomiting

Mortimer, T. L., Mabin, T., & Engelbrecht, A. (2019) · Future Oncology · doi:10.2217/fon-2018-0530 · Cited by 43

Nausea-Induced 5-HT Release in the Interoceptive Insular Cortex and Regulation by Monoacylglycerol Lipase (MAGL) Inhibition and Cannabidiol

Limebeer, C. L., Rock, E. M., Sharkey, K. A., & Parker, L. A. (2018) · eNeuro · doi:10.1523/eneuro.0256-18.2018 · Cited by 42

Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids

Franco, R., Rivas‐Santisteban, R., Reyes‐Resina, I., Casanovas, M., Pérez-Olives, C., Ferreiro‐Vera, C., Navarro, G., de Medina, V. S., & Nadal, X. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104801 · Cited by 42

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders

Scarante, F. F., Ribeiro, M. A., Almeida-Santos, A. F., Guimarães, F. S., & Campos, A. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.618065 · Cited by 44

Differential contribution of CB1, CB2, 5‐HT1A, and PPAR‐γ receptors to cannabidiol effects on ischemia‐induced emotional and cognitive impairments

Mori, M., Meyer, E., da Silva, F. F., Milani, H., Guimarães, F. S., & de Oliveira, R. M. W. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15134 · Cited by 40

Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

Rock, E. M., Limebeer, C. L., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0041 · Cited by 39

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain

Bernatonienė, J., Ščiupokas, A., Kopustinskienė, D. M., & Petrikonis, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071799 · Cited by 42

Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?

Starowicz, K., & Marzo, V. D. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.075 · Cited by 39

Cannabidiol: an alternative therapeutic agent for oral mucositis?

Cuba, L. F., Salum, F. G., Cherubini, K., & de Figueiredo, M. A. Z. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12504 · Cited by 38

Vapor inhalation of cannabidiol (CBD) in rats

Paydar, M. J., Creehan, K. M., Kerr, T. M., & Taffe, M. A. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172741 · Cited by 38

Cannabidiol Indirectly Activates 5-HT1A Somatodendritic Autoreceptors to Attenuate Vomiting and Nausea

Rock, E. M. (2011) · The Atrium (University of Guelph)

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151

Cannabidiolic acid enhances 5-HT1A receptor activation and prevents vomiting in Suncus murinus and nausea-like behaviour in rats with greater potency and selectivity than cannabidiol

Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., Stott, C. G., Javid, F. A., Parker, L. A., & Pertwee, R. G. (2013) · University of Huddersfield Repository (University of Huddersfield)

Regulation of nausea and vomiting by cannabinoids

Parker, L. A., Rock, E. M., & Limebeer, C. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 267

Electrophysiological study of the effect of cannabidiol on the dorsal raphe nucleus serotonergic neurons

Aostri, E., Pineda, J., & Mendiguren, A. (2017) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-03-05083